David Larsen
Stock Analyst at BTIG
(1.85)
# 1,374
Out of 4,650 analysts
70
Total ratings
33.33%
Success rate
-7.95%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Buy | $60 → $50 | $30.90 | +61.81% | 2 | Oct 24, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $15.78 | +26.74% | 2 | Oct 3, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $60 → $70 | $56.08 | +24.82% | 1 | Oct 3, 2024 | |
| DH Definitive Healthcare | Initiates: Buy | $7 | $4.22 | +65.88% | 1 | Sep 17, 2024 | |
| CCSI Consensus Cloud Solutions | Upgrades: Buy | $30 | $21.49 | +39.60% | 2 | Aug 21, 2024 | |
| PGNY Progyny | Downgrades: Neutral | n/a | $15.83 | - | 3 | Aug 7, 2024 | |
| VEEV Veeva Systems | Initiates: Buy | $240 | $212.13 | +13.14% | 1 | Jul 9, 2024 | |
| DCGO DocGo | Maintains: Buy | $11 → $7 | $3.47 | +101.73% | 4 | May 9, 2024 | |
| LFMD LifeMD | Maintains: Buy | $13 → $14 | $4.40 | +218.54% | 3 | Apr 23, 2024 | |
| PIII P3 Health Partners | Downgrades: Neutral | n/a | $0.39 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $110 | $87.82 | +25.26% | 3 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $285 | $217.54 | +31.01% | 1 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $40.39 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $41.42 | - | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $23.61 | +90.60% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $7.93 | +164.82% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.70 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.38 | - | 2 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $17.73 | +97.41% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.18 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $95 | $7.18 | +1,223.12% | 2 | Oct 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $9.93 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $110.87 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $508.95 | -68.56% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $9.44 | +641.53% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $71.11 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $57.36 | +48.19% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $13.31 | +72.80% | 1 | Nov 2, 2017 |
Simulations Plus
Oct 24, 2024
Maintains: Buy
Price Target: $60 → $50
Current: $30.90
Upside: +61.81%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $15.78
Upside: +26.74%
Astrana Health
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $56.08
Upside: +24.82%
Definitive Healthcare
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $4.22
Upside: +65.88%
Consensus Cloud Solutions
Aug 21, 2024
Upgrades: Buy
Price Target: $30
Current: $21.49
Upside: +39.60%
Progyny
Aug 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $15.83
Upside: -
Veeva Systems
Jul 9, 2024
Initiates: Buy
Price Target: $240
Current: $212.13
Upside: +13.14%
DocGo
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $3.47
Upside: +101.73%
LifeMD
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $4.40
Upside: +218.54%
P3 Health Partners
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.39
Upside: -
Mar 20, 2024
Maintains: Buy
Price Target: $100 → $110
Current: $87.82
Upside: +25.26%
Feb 13, 2024
Initiates: Buy
Price Target: $285
Current: $217.54
Upside: +31.01%
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $40.39
Upside: -
Oct 13, 2022
Initiates: Neutral
Price Target: n/a
Current: $41.42
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $23.61
Upside: +90.60%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $7.93
Upside: +164.82%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $2.70
Upside: -
Apr 29, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.38
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $17.73
Upside: +97.41%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $9.18
Upside: -
Oct 26, 2021
Maintains: Buy
Price Target: $80 → $95
Current: $7.18
Upside: +1,223.12%
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $9.93
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $110.87
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $508.95
Upside: -68.56%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $9.44
Upside: +641.53%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $71.11
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $57.36
Upside: +48.19%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $13.31
Upside: +72.80%